Efficacy and safety of vedolizumab in the treatment of patients with inflammatory bowel disease: A systematic review and meta‑analysis of randomized controlled trials

Few studies have thoroughly assessed the efficacy and safety of vedolizumab (VDZ) in the treatment of inflammatory bowel disease (IBD). Therefore, this systematic review and meta-analysis was performed to further evaluate this association. PubMed, Embase, and the Cochrane databases were searched unt...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Hui-Jun, Bie, Cai-Qun, Guo, Li-Liangzi, Zhong, Li-Xian, Tang, Shao-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203751/
https://www.ncbi.nlm.nih.gov/pubmed/37229320
http://dx.doi.org/10.3892/etm.2023.11997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203751/
https://www.ncbi.nlm.nih.gov/pubmed/37229320
http://dx.doi.org/10.3892/etm.2023.11997

Ejemplares similares